Trans-Oral Robotic Surgery - The Royal Adelaid - Global Robotics ...
Trans-Oral Robotic Surgery - The Royal Adelaid - Global Robotics ...
Trans-Oral Robotic Surgery - The Royal Adelaid - Global Robotics ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
World <strong>Robotic</strong> Symposium 2011<br />
<strong>Trans</strong>oral <strong>Robotic</strong> <strong>Surgery</strong> (TORS)<br />
Loews Miami Beach Hotel<br />
Miami Beach, Florida<br />
June 27-28, 2011<br />
<strong>Trans</strong>-<strong>Oral</strong> <strong>Robotic</strong> <strong>Surgery</strong><br />
<strong>The</strong> <strong>Royal</strong> <strong>Adelaid</strong>e Hospital Experience<br />
SUREN KRISHNAN OAM, FRACS, MBBS (<strong>Adelaid</strong>e)<br />
CHAIRMAN,<br />
DEPARMENT OF OTORHINOLARYNGOLOGY, HEAD & NECK SURGERY,<br />
ROYAL ADELAIDE HOSPITAL,<br />
ADELAIDE,<br />
SOUTH AUSTRALIA.<br />
CLINICAL ASSOCIATE PROFESSOR OF SURGERY,<br />
UNIVERSITY OF ADELAIDE, SOUTH AUSTRALIA.<br />
VISITING PROFESSOR OF HEAD & NECK SURGERY,<br />
SUN YAT SEN UNIVERSITY, GUANGZHOU, CHINA.
ASOHNS 2012 Annual Scientific Meeting - <strong>Global</strong><br />
Perspectives<br />
<strong>Adelaid</strong>e 31 Mar - 4 Apr 2012.<br />
� International Keynote Speakers:<br />
� Professor Eric M. Genden, MD, FACS<br />
Professor of Otolaryngology/Head and Neck <strong>Surgery</strong> and Immunobiology, Mount Sinai School<br />
of Medicine, New York, USA<br />
� Professor Antony Narula, FRCS<br />
Consultant Otolaryngologist, St Mary's Hospital, London and Honorary Professor, Middlesex<br />
University, England<br />
� Professor Gerard O'Donoghue, FRCS<br />
Consultant Neuro-otologist, Queens Medical Centre, Nottingham and Professor of<br />
Otolaryngology, University of Nottingham, England<br />
� Professor Rodney J. Schlosser, MD FACS<br />
Professor and Director of Rhinology, Medical University of South Carolina, USA<br />
� Associate Professor Edward M. Weaver, MD MPH FACS<br />
Associate Professor of Otolaryngology/Head & Neck <strong>Surgery</strong>; Chief of Sleep <strong>Surgery</strong>,<br />
University of Washington, Seattle, Washington, USA
DEPARTMENT OF OTOLARYNGOLOGY,<br />
HEAD AND NECK SURGERY<br />
ROYAL ADELAIDE HOSPITAL<br />
• THE CONTRIBUTORS<br />
– ANSTEY GILES 1920s<br />
– THE LATE JEFF ROZENBILDS<br />
– THE LATE P.V. RAJAGOPALAN<br />
– RON GRISTWOOD<br />
– DAN HAINS<br />
– DARCY ECONOMOS<br />
• THE CURRENT DEPARTMENT<br />
– MICHAEL JAY<br />
– PROFESSOR P.J. WORMALD<br />
– GUY REES<br />
– MICHAEL SCHULTZ<br />
– SAM ARENA<br />
– STEVE FLOREANI<br />
– MICHAEL SWITAJEWSKI<br />
– MARK SCHEMBRI<br />
– SURESH RAJAPAKSA<br />
– IAN WONG<br />
THE ROYAL ADELAIDE HOSPITAL<br />
ADELAIDE<br />
SOUTH AUSTRALIA
HEAD & NECK CONSULTATIVE CLINIC<br />
ROYAL ADELAIDE HOSPITAL<br />
� RADIOLOGIST<br />
� STEVE CHRYSSIDIS (DAVID DONOVAN, DAN MADIGAN, ANDY WHYTE)<br />
� PATHOLOGIST<br />
� PETER BIGNOLD<br />
� RADIATION ONCOLOGISTS<br />
� M.BORG, M.PENNIMENT, D.ROOS, R.GOWDA<br />
� MEDICAL ONCOLOGISTS<br />
� A.TAYLOR, N. SINGHAL (M.BROWN, M.KEEFE, S.SELVA)<br />
� ORAL SURGEONS<br />
� A.GOSS, P.SAMBROOK, (R.JONES, P.DUKE, P.PIRGOUSIS)<br />
� PLASTICS & RECONSTRUCTIVE SURGEONS<br />
� Y. CAPLASH, R. COREN (T.EDWARDS,,J.KATSAROS)<br />
� GENERAL SURGEONS<br />
� B.COVENTRY, G.GILL<br />
� BREAST / ENDOCRINE SURGEONS<br />
� J.KOLLIAS, M.BOCHNER (P.MALYCHA)<br />
� OTOLARYNGOLOGIST, HEAD & NECK SURGEONS<br />
� S.KRISHNAN, G.REES, M.SWITAJEWSKI, S.ARENA<br />
� (DAN HAINS, DARCY ECONOMOS, JEFF ROZENBILDS)<br />
� SPEECH PATHOLOGISTS<br />
� R.BURNETT, H.BARON, J.BEATTY<br />
� SPECIAL NEEDS DENTISTRY<br />
� ELIZ COATS, S. LIBERALI, B. SCOPACASA<br />
� DIETITIAN<br />
� R. KURMIS (M.HERRIOT, D.CLEGHORN)<br />
� SOCIAL WORKERS
TRANS ORAL ROBOTIC SURGERY<br />
� Why TORS<br />
� <strong>The</strong> Journey<br />
� <strong>The</strong> <strong>Royal</strong> <strong>Adelaid</strong>e Hospital Experience<br />
� Some data<br />
� <strong>The</strong> Future
WHY TORS<br />
� TREATMENT TOXICITY<br />
� DYSPHAGIA<br />
� OSTEORADIONECROSIS<br />
� TUMOUR BIOLOGY V HOST BIOLOGY<br />
� HPV<br />
� TECHNOLOGY<br />
� VISUAL AND INSTRUMENT ACCESS<br />
� NO TREMOR<br />
� REDUCED MORBIDITY
WHY <strong>Trans</strong> <strong>Oral</strong> <strong>Robotic</strong> <strong>Surgery</strong> ?<br />
Challenges of <strong>Trans</strong> <strong>Oral</strong> Laser <strong>Surgery</strong><br />
with Microscope<br />
� Ergonomics<br />
� Counter-intuitive motion<br />
� Hand / eye alignment<br />
� Instrument tremor<br />
� Non-wristed instruments<br />
� 2-D vision<br />
� Straight Line Optics<br />
� Alignment of CO2 beam<br />
� Positioning and Repositioning<br />
� Learning curve
THE ADELAIDE JOURNEY
PICKARD FOUNDATION DONATION 2004
St John of God<br />
Subiaco, Perth<br />
2003<br />
2004<br />
2005<br />
2007<br />
da Vinci® Australia – 5 /New Zealand - 2<br />
St Vincent’s Private Hospital<br />
Sydney Mercy Ascot Hospital<br />
<strong>Royal</strong> <strong>Adelaid</strong>e Hospital<br />
Auckland<br />
<strong>Adelaid</strong>e<br />
Epworth Eastern Private Hospital<br />
Richmond, Melbourne<br />
Epworth Private Hospital<br />
Box Hill<br />
<strong>The</strong> Grace Hospital<br />
Tauranga
CNAHS ROBOTIC SURGERY COMMITTEE<br />
� DRAFT PROPOSAL<br />
� DEMONSTRATE A NEED<br />
� COST OF CURRENT PRACTICE<br />
� LENGTH OF STAY IN CURRENT PRACTICE<br />
� TRAINING IN ROBOTICS<br />
� MENTORING<br />
� DOCUMENTATION OF EVERY CASE<br />
� COST OF INSTRUMENTS<br />
� TIME OF SETUP<br />
� TIME OF SURGERY<br />
� BLOOD LOSS<br />
� ICU STAY<br />
� LENGTH OF STAY
ASOHNS A.S.M. ADELAIDE 2007
VISIT TO HOSPITAL UNIVERSITY PENNSYLVANIA,<br />
PHILADELPHIA<br />
FEBRUARY 2008<br />
Leviticus XXV:10, "Proclaim liberty<br />
throughout all the land, unto all the<br />
inhabitants thereof."
Professor Gregory Weinstein<br />
Deputy Chairman<br />
Otolaryngology and Head and Neck <strong>Surgery</strong><br />
Hospital of the University of Pennsylvania
Professor Bert O’Malley<br />
Chairman<br />
Otolaryngology and Head and Neck <strong>Surgery</strong><br />
Hospital of the University of Pennsylvania
HOSPITAL UNIVERSITY PENNSYLVANIA,<br />
PIG MODEL LABORATORY, PHILADELPHIA<br />
FEBRUARY 2008
VISIT TO AND ROBOTIC COURSE<br />
INTUITIVE LABORATORIES, SUNNYVALE,<br />
CALIFORNIA
VISIT TO AND CADAVERIC COURSE<br />
INTUITIVE LABORATORIES, SUNNYVALE,<br />
CALIFORNIA<br />
JULY 2008
RAH TRIAL RUN
Julie Bowd & Stuart Winter
J-C Hodge and David Howe
FK<br />
Boyle Davis
FK RETRACTOR - LARYNGEAL SURGERY
<strong>The</strong> Instruments
<strong>The</strong> Pre Resection Assessment<br />
SCOPE ACCESS<br />
TELESCOPY<br />
PALPATION<br />
NIELS KOKOT
Haemostasis<br />
MICROFRANCE<br />
LIGACLIP<br />
HAEMOSTASIS
LINGUAL ARTERY<br />
TITANIUM TOXICITY!
Haemostasis
KEYS TO SUCCESS<br />
� GOOD NURSE / TECHNICIAN<br />
� GOOD SURGICAL ASSISTANT<br />
� GOOD EXPOSURE<br />
� BOYLE – DAVIS GAG (for most procedures)<br />
� F-K RETRACTOR (for larynx)<br />
� WRISTED INSTRUMENTS WITH BIPOLAR<br />
� MICROLARYNGEAL CLIP APPLICATORS<br />
(GOOD SURGICAL ASSISTANT)
TRANS ORAL ROBOTIC SURGERY<br />
IN<br />
HEAD AND NECK CANCER<br />
THE ROYAL ADELAIDE HOSPITAL EXPERIENCE
TORS - RAH EXPERIENCE<br />
� 78 CASES<br />
� 48 OROPHARYNGEAL CANCERS<br />
� 4 PARAPHARYNGEAL SPACE TUMOURS<br />
� 4 SUPRAGLOTTIC LARYNGECTOMIES<br />
� 2 VERTICAL PARTIAL LARYNGECTOMIES<br />
� 16 SLEEP APNEA SURGERIES
TORS - VERTICAL PARTIAL LARYNGECTOMY<br />
en bloc technique
TORS - VERTICAL PARTIAL LARYNGECTOMY<br />
en bloc with laser
SUPRAGLOTTIC LARYNGECTOMY –<br />
en bloc technique
PARAPHARYNGEAL SPACE<br />
TUMOUR SURGERY<br />
CONTROLLED VISUAL ACCESS OF SUPERIOR LIMIT OF TUMOUR<br />
AVOID MORBIDITIES OF EXTERNAL ACCESS<br />
-FACIAL NERVE<br />
-SCAR<br />
-PAROTID SURGERY & FREY’S SYNDROME<br />
-FIRST BITE SYNDROME
PARAPHARYNGEAL SPACE<br />
TYPE IV SECOND BRANCHIAL ARCH CYST<br />
CONTROLLED ACCESS TO INFLAMMATORY, ADHERENT MASSES IN PPS
TRANS ORAL ROBOTIC SURGERY<br />
AT<br />
THE ROYAL ADELAIDE HOSPITAL<br />
IMAGE GUIDED RETRO PHARYNGEAL LYMPH NODE DISSECTION
OVERVIEW OF ADULT SNORING<br />
AND<br />
SLEEP APNOEA<br />
WORLD ROBOTIC SURGERY MEETING, ORLANDO, APRIL 2010<br />
Mr. Suren Krishnan O.A.M., F.R.A.C.S.<br />
Clinical Associate Professor of <strong>Surgery</strong><br />
University of <strong>Adelaid</strong>e<br />
Head of Department<br />
Otolaryngology, Head and Neck <strong>Surgery</strong><br />
<strong>Royal</strong> <strong>Adelaid</strong>e Hospital<br />
Mr. Sam Robinson F.R.A.C.S.<br />
Consultant Surgeon<br />
Flinders Medical Centre<br />
<strong>Adelaid</strong>e<br />
South Australia
VALE<br />
DR. SAMUEL ROBINSON<br />
1967 -2010
UPP technique<br />
Submucosal uvulopalatopharyngoplasty<br />
(Modified from Friedman M, Landsberg R, Tanyeri H.)<br />
Submucosal uvulopalatopharyngoplasty.<br />
Op Tech Otolaryngol Head Neck Surg 2000;11:26–9.)
Expansion sphincter pharyngoplasty<br />
K. Pang, T. Woodson
Palatal Advancement :<br />
<strong>The</strong> concept
Palatal advancement
Submucosal Lingualplasty<br />
� Robinson S, developed 2006. In press<br />
Atlas of snoring & sleep apnea surgery<br />
Ed; Friedman M, 2008.<br />
� Involves dissection in a plane just<br />
superficial to n-v bundles identified<br />
with U/S, then developing/protecting<br />
this plane with a malleable retractor<br />
� 15-25ml excised including muscle<br />
superficial & lateral to n-v bundles.<br />
Minor pain.<br />
� Outcomes study ongoing.
Submucosal Lingualplasty
TORS – TONGUE BASE AND<br />
OROPHARYNX RESECTIONS
� ABSTRACT<br />
�<br />
<strong>Trans</strong>oral Lateral Oropharyngectomy<br />
for Squamous Cell Carcinoma of the Tonsillar Region<br />
I. Technique, Complications, and Functional Results<br />
F. Christopher Holsinger, MD; Andrew J. McWhorter, MD; Madeleine Ménard, MD;<br />
Dominique Garcia, MD; Ollivier Laccourreye, MD<br />
Arch Otolaryngol Head Neck Surg. 2005;131:583-591.<br />
Objectives To describe the surgical technique for transoral lateral oropharyngectomy (TLO) and its safety, postoperative<br />
management, complications, and functional outcomes.<br />
� Design A 20-year retrospective case series review. Mean follow-up was 10 years. All but 10 patients were followed up<br />
until the fifth postoperative year or death.<br />
� Setting Academic, tertiary referral center.<br />
� Patients A total of 191 patients who underwent TLO for selected invasive squamous cell carcinoma of the tonsil and/or<br />
tonsillar fossa.<br />
� Interventions Ten patients had received preoperative radiation therapy. Induction chemotherapy was used in 153 patients<br />
(80.3%). An associated neck dissection was performed in 148 patients (77.5%). Postoperative radiation therapy was<br />
administered to 52 patients (28.7%).<br />
� Main Outcome Measures Overall survival rate, intraoperative mortality, and perioperative mortality were determined.<br />
<strong>The</strong> need for and length of nasogastric tube feeding and tracheotomy were calculated. <strong>The</strong> incidence of significant<br />
postoperative surgical and medical complications was recorded.<br />
� Results No intraoperative mortality occurred, but 5 patients (2.6%) died in the immediate postoperative period, 3 from<br />
medical complications and 2 from unknown causes. In this series, the internal carotid artery was never injured, and no<br />
cutaneous-oropharyngeal fistulas were apparent. <strong>The</strong> incidence of significant surgical complications from the oropharynx<br />
was 6.3%. Nasopharyngeal reflux and severe rhinolalia were the most common complications, occurring in 9 patients.<br />
Increasing tobacco use was statistically correlated with an increase in postoperative pneumonia from aspiration (P = .05)<br />
but no surgical complications. Seven patients (3.7%) had a temporary tracheotomy for a mean of 5 days. One hundred<br />
twelve patients (58.6%) had a nasogastric tube inserted for a mean of 6 days. No patients had a permanent gastrostomy or<br />
tracheotomy tube. <strong>The</strong> mean duration of hospitalization was 9 days. <strong>The</strong> duration of hospitalization was statistically<br />
correlated with the need for nasogastric tube placement and its duration (P
<strong>Trans</strong> <strong>Oral</strong><br />
Lateral Oropharyngectomy
Structures identified during dissection
Resection Complete<br />
1) SUTURE POSTERIOR PHARYNGEAL WALL TO POSTERIOR LIP<br />
(NASAL SURFACE) OF REMNANT UVULA<br />
(2) INJECT BOTOX INTO REMINING PALATAL MUSCULATURE<br />
(3) PATIENT HAS NGT FOR 3 OR 4 DAYS AND DISCHARGED<br />
HOME WHENSWALLOWS SAFELY
TRANS ORAL ROBOTIC SURGERY<br />
AT<br />
THE ROYAL ADELAIDE HOSPITAL
TORS - RAH EXPERIENCE<br />
� 48 preliminary analysis<br />
ROBOTIC PATIENTS BY CANCER STAGING<br />
10%<br />
63%<br />
20%<br />
7%<br />
I<br />
II<br />
III<br />
IV
MONTHS POST-SURGERY<br />
30<br />
23<br />
15<br />
8<br />
0<br />
POST-TREATMENT RECURRENCE BY SITE<br />
1 2 3 4<br />
INDIVIDUAL PATIENTS<br />
ALL 4 LOCAL RECURRENCES WERE PALLIATIVE RESECTIONS<br />
LOCAL<br />
NECK<br />
DISTANT<br />
( 2 RECURRENCES AFTER R/T, 2 LARGE T4s ALL<br />
RESECTIONS FOR SYMPTOM RELIEF)<br />
ONE T1N1 PATIENT DEVELOPED METASTASES
MONTHS POST ROBOTIC SURGERY<br />
30<br />
23<br />
15<br />
8<br />
0<br />
SURVIVAL TIME BY T STAGE FOR DECEASED<br />
T1N2B T1N2 T2N2B T2N2C T4aM0<br />
T STAGE
CURRENT REMISSION POST ROBOTIC SURGERY BY CANCER STAGE<br />
MONTHS POST ROBOTIC SURGERY<br />
MONTHS POST ROBOTIC SURGERY<br />
30<br />
23<br />
15<br />
30<br />
23<br />
15<br />
8<br />
0<br />
8<br />
0<br />
1 2 3 4 5 6 7 8 9 1011121314151617181920212223242526<br />
INDIVIUAL PATIENTS<br />
I (n = 4)<br />
II (n = 8)<br />
III (n = 3)<br />
IV (n = 26)<br />
RECURRENCES POST ROBOTIC SURGERY BY TN STAGE<br />
Tis N0 T2N0 T1N2B TXN2B T2N2B T2N2C T4aN0<br />
TN STAGE<br />
CURRENT LENGTHS OF REMISSION POST ROBOTIC SURGERY BY N STAGE<br />
MONTHS SINCE ROBOTIC SURGERY<br />
30<br />
23<br />
15<br />
8<br />
0<br />
CURRENT LENGTHS OF REMISSION POST ROBOTIC SURGERY BY T STAGE<br />
MONTHS POST ROBOTIC SURGERY<br />
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15<br />
30<br />
23<br />
15<br />
8<br />
0<br />
INDIVIDUAL PATIENTS<br />
1 2 3 4 5 6 7 8 9 10 11 1213141516171819202122<br />
INDIVIDUAL PATIENTS<br />
N0<br />
N1<br />
N2A<br />
N2B<br />
N2C<br />
N3<br />
T0 (n = 1)<br />
Tis (n = 1)<br />
T1(n = 11)<br />
T2 (n = 22)<br />
T3 (n = 4)<br />
T4a (n = 3)<br />
TX (n = 1)
TORS - RAH EXPERIENCE<br />
� Data on 15 cases from first 12 months presented<br />
� 15 Cancers<br />
� 11 Male<br />
� 4 Female<br />
� Average Age 53.6 years
TORS - RAH EXPERIENCE<br />
CASE MIX<br />
� 3 <strong>Oral</strong> Cavity<br />
� 8 Oropharynx<br />
� 4 Larynx<br />
� 2 Vertical Partial Laryngectomy<br />
� 2 Supraglottic Laryngectomy
TORS - RAH EXPERIENCE<br />
STAGE OF DISEASE<br />
AJCC<br />
� 4 Stage I<br />
� 4 Stage II<br />
� 1 Stage III<br />
� 6 Stage IV<br />
UICC T Stage<br />
� 8 T1<br />
� 7 T2<br />
UICC N Stage<br />
� 8 N0<br />
� 1 N1<br />
� 6 N2
TORS - RAH EXPERIENCE<br />
OPERATIVE EVENTS<br />
� Robot Setup Time average - 34.5 minutes<br />
� Operation Time average - 50 minutes<br />
� Radical Tonsil Tumour Excision - 27 minutes<br />
� W L E of Tongue Base with Buccinator Myomucosal flap inset - 105 minutes<br />
MARGINS<br />
� 9 Clear<br />
� 2 Positive<br />
� 2 No Cancer (previous excisional biopsy)<br />
� 2 Doubtful (Piecemeal Supraglottic Resections)<br />
NECK DISSECTIONS<br />
� At same sitting<br />
� At 2 weeks post TORS<br />
RECONSTRUCTIONS<br />
� Healing by secondary intention<br />
� <strong>Robotic</strong> Buccinator and FAMM Flap<br />
� Open Nasolabial Flap
TORS - RAH EXPERIENCE<br />
POST-OPERATIVE EVENTS<br />
HOSPITAL STAY<br />
� 3 to 6 days<br />
� Limited by recovery from neck dissection<br />
COMPLICATIONS<br />
� 0 Intra-operative<br />
� 5 Early Post-operative<br />
� 3 Pneumonia<br />
� 1 Chyle leak<br />
� 1 Volvulus<br />
DYSARTHRIA<br />
� 1 Tethered by Buccinator Flap until Flap divided<br />
SWALLOWING<br />
� 11 <strong>Oral</strong> Intake after Day 3<br />
� 1 PEG dependent for 6 months (Patient with 3 rd primary UADT SCC)<br />
� 1 PEG supplement<br />
� 1 PEG dependent after Post-operative Radiotherapy<br />
� 1 PEG dependent after CRT<br />
FOLLOW UP<br />
� Longest 12 months<br />
� 12 Free of disease
KEYS TO SUCCESS IN TORS<br />
� GOOD TRAINING<br />
� EXPERIENCE WITH TRANS ORAL LASER SURGERY<br />
� GOOD NURSE / TECHNICIAN<br />
� GOOD SURGICAL ASSISTANT<br />
� GOOD EXPOSURE<br />
� BOYLE – DAVIS GAG<br />
� F-K RETRACTOR<br />
� OBSSESSIVE HAEMOSTASIS<br />
� WRISTED INSTRUMENTS WITH BIPOLAR<br />
� MICROLARYNGEAL CLIP APPLICATORS
TORS - SUMMARY<br />
� This is a new surgical technique & offers another option for patients<br />
� Better visualisation<br />
� More accurate tissue resection<br />
� Potential to reduce tissue trauma<br />
� Surgeon OHW&S<br />
� Ergonomics<br />
� Posture<br />
� Fatigue<br />
� Disadvantages<br />
� No true haptic feedback<br />
� Cost<br />
� Each case is currently treated as a research outcome evaluation<br />
� Accumulation of case experience<br />
� Reporting of cases<br />
� Assessment of outcomes of function, quality of life and costs<br />
� Establishment of National and International database
THE FUTURE
� Our legions are brimful, our cause is ripe;<br />
<strong>The</strong> enemy increaseth every day; We,<br />
at the height, are ready to decline.<br />
� <strong>The</strong>re is a tide in the affairs of men<br />
Which taken at the flood, leads on to fortune;<br />
Omitted, all the voyage of their life<br />
Is bound in shallows and in miseries.<br />
� Shakespeare , Julius Caesar(4.3.218)<br />
VALE<br />
CHRIS O’BRIEN AO, PhD, MS, FRACS<br />
January 1952 - June 2009